![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KS Selander, J Monkkonen, EK Karhukorpi, P Harkonen, R Hannuniemi and HK Vaananen
Department of Anatomy, University of Oulu, Finland.
Bisphosphonates (BPs), such as clodronate and pamidronate, are inhibitors of bone resorption and are used on a widespread basis in the treatment of hyper-resorptive bone diseases. At the cellular level, BPs inhibit osteoclasts, but the precise molecular mechanisms are unclear. BPs have also been shown to affect the survival of macrophages, cells ontogenetically related to osteoclasts. We show that both clodronate and pamidronate induce apoptosis in isolated osteoclasts. Clodronate, when administered in liposomes, also induced apoptosis in rat peritoneal macrophages in vitro and in liver macrophages of mice in vivo but not in murine macrophage-like RAW-264 cells. The subcellular localization and staining intensity of Bcl-2, an anti-apoptotic protein known to protect several cell types against drug-induced apoptosis, were similar in RAW-264 and peritoneal macrophage cells, as revealed by immunofluorescence. The clodronate-induced apoptotic pathway was further characterized in isolated osteoclasts cultured on glass coverslips through the use of clodronate-containing liposomes and several inhibitors of the apoptotic cascade. None of the agents tested could totally prevent clodronate-induced osteoclast death. Partial protection was, however, obtained by the addition of staurosporine or homocysteine. The results suggest that primarily cytoplasmic, protein kinase C-activated mechanisms are involved in the execution of clodronate-induced apoptosis of osteoclasts.
This article has been cited by other articles:
|
|
 |
|
  N. R. Miselis, Z. J. Wu, N. Van Rooijen, and A. B. Kane Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma Mol. Cancer Ther., April 1, 2008; 7(4): 788 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Clarke, H. Alizadeh, and J. Y. Niederkorn Intracorneal Instillation of Latex Beads Induces Macrophage-Dependent Protection against Acanthamoeba Keratitis Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4917 - 4925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhao, F. P. Ross, and S. L. Teitelbaum Unoccupied {alpha}v{beta}3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal Mol. Endocrinol., March 1, 2005; 19(3): 771 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Green Bisphosphonates: Preclinical Review Oncologist, September 1, 2004; 9(suppl_4): 3 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jiang and D. S. Pisetsky The Effect of Dexamethasone on the Generation of Plasma DNA from Dead and Dying Cells Am. J. Pathol., May 1, 2004; 164(5): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Santini, U. Vespasiani Gentilucci, B. Vincenzi, A. Picardi, F. Vasaturo, A. La Cesa, N. Onori, S. Scarpa, and G. Tonini The antineoplastic role of bisphosphonates: from basic research to clinical evidence Ann. Onc., October 1, 2003; 14(10): 1468 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jiang, C. F. Reich III, and D. S. Pisetsky Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells Blood, September 15, 2003; 102(6): 2243 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Danenberg, I. Fishbein, J. Gao, J. Monkkonen, R. Reich, I. Gati, E. Moerman, and G. Golomb Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits Circulation, July 30, 2002; 106(5): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Virtanen, H. K. Vaananen, P. L. Harkonen, and P. T. Lakkakorpi Alendronate Inhibits Invasion of PC-3 Prostate Cancer Cells by Affecting the Mevalonate Pathway Cancer Res., May 1, 2002; 62(9): 2708 - 2714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Lehenkari, M. Kellinsalmi, J. P. Napankangas, K. V. Ylitalo, J. Monkkonen, M. J. Rogers, A. Azhayev, H. K. Vaananen, and I. E. Hassinen Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite Mol. Pharmacol., May 1, 2002; 61(5): 1255 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Dunford, K. Thompson, F. P. Coxon, S. P. Luckman, F. M. Hahn, C. D. Poulter, F. H. Ebetino, and M. J. Rogers Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 235 - 242. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Saarto, C. Blomqvist, P. Virkkunen, and I. Elomaa Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial J. Clin. Oncol., January 1, 2001; 19(1): 10 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Alatalo, J. M. Halleen, T. A. Hentunen, J. Monkkonen, and H. K. Vaananen Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium Clin. Chem., November 1, 2000; 46(11): 1751 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Reszka, J. M. Halasy-Nagy, P. J. Masarachia, and G. A. Rodan Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis. A LINK BETWEEN INHIBITION OF THE MEVALONATE PATHWAY AND REGULATION OF AN APOPTOSIS-PROMOTING KINASE J. Biol. Chem., December 3, 1999; 274(49): 34967 - 34973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Srivastava and U. S. Alon Bisphosphonates: From Grandparents to Grandchildren Clinical Pediatrics, November 1, 1999; 38(12): 687 - 702. [Abstract] [PDF]
|
|
|
|
 |
|
 P. J. Richards, N. Amos, A. S. Williams, and B. D. Williams Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo Rheumatology, October 1, 1999; 38(10): 984 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Richards, A. S. Williams, R. M. Goodfellow, and B. D. Williams Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis Rheumatology, September 1, 1999; 38(9): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Coxon, H. L. Benford, R. G. G. Russell, and M. J. Rogers Protein Synthesis Is Required for Caspase Activation and Induction of Apoptosis by Bisphosphonate Drugs Mol. Pharmacol., October 1, 1998; 54(4): 631 - 638. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kojima, A. Nemoto, T. Uemura, R. Honma, M. Ogura, and Y.-k. Liu rDRAK1, a Novel Kinase Related to Apoptosis, Is Strongly Expressed in Active Osteoclasts and Induces Apoptosis J. Biol. Chem., May 25, 2001; 276(22): 19238 - 19243. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
